{"product_id":"global-nucleic-acid-multiplex-assays-market-growth-status-and-outlook-2023-2029","title":"Global Nucleic Acid Multiplex Assays Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Nucleic Acid Multiplex Assays Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eMultiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Nucleic Acid Multiplex Assays Industry Forecast” looks at past sales and reviews total world Nucleic Acid Multiplex Assays sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Multiplex Assays sales for 2023 through 2029. With Nucleic Acid Multiplex Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Multiplex Assays industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Nucleic Acid Multiplex Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Multiplex Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Multiplex Assays market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Multiplex Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Multiplex Assays.\u003c\/p\u003e\n\n\u003cp\u003eThe global Nucleic Acid Multiplex Assays market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Nucleic Acid Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Nucleic Acid Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Nucleic Acid Multiplex Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Nucleic Acid Multiplex Assays players cover Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Multiplex Assays market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nPlanar Nucleic Acid Assays\u003cbr\u003e\nBead-Based Nucleic Acid Assays\u003cbr\u003e\nOther Nucleic Acid Assays\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nPharmaceutical \u0026amp; Biotechnology Companies\u003cbr\u003e\nHospitals \u0026amp; Research Institutes\u003cbr\u003e\nReference Laboratories\u003cbr\u003e\nOther End Users\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nAbcam\u003cbr\u003e\nBecton\u003cbr\u003e\nDickinson and Company\u003cbr\u003e\nMerck KGaA\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nBio-Techne\u003cbr\u003e\nShimadzu Biotech\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nBio-Rad Laboratories\u003cbr\u003e\nQiagen\u003cbr\u003e\nLuminex Corporation\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 102 Pages \/ MCW16235169","offer_id":47651146203442,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-nucleic-acid-multiplex-assays-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}